Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Is Prelude Prld Stock Declining Price At 4.08 Down 7.27 20260404 Ktos Stock Analysis Kratos Defense And Security Solutions Inc. Down 3.99 To 67.7 20260401 Is Templeton Tdf Stock Ready To Drop Price At 10.51 Down 0.76 20260406 Is Cal Water Cwt Stock Testing Support Price At 45.90 Down 0.76 20260406 Is Abbvie Abbv Stock Cheap At Current Price Price At 207.12 Down 0.82 20260406 XNCR Xencor Inc reports far narrower Q4 2025 loss than expected alongside 137 year over year revenue growth ALX Alexanders Inc shares climb 345 percent following the release of its Q4 2025 earnings report GYRE Gyre Therapeutics Inc notches 102 percent year over year revenue growth shares climb despite modest EPS miss FDP Fresh Del Monte Produce Inc reports a massive fourth quarter 2025 earnings beat shares rise modestly today Market Recap Tech leads sector gains while consumer lags and markets dip slightly SherwinWilliams SHW Q1 2026 Earnings Preview Revenue Growth Projected EPS Upside Predictability Remains Limited FedEx Corp FDX SEC Greenlights FedEx Freight Spinoff Amid Strategic Corporate Restructuring CalMaine CALM Stock 13D Filings 162 20260420 NVVE Nuvve Holding releases Q2 2025 earnings with 221 per share loss stock dips 033 today Highland HFROA Stock Technical Momentum Review Norfolk Southern Corporation NSC Bullish Sentiment Rises Amid Union Pacific Merger Speculation and Sector Tailwinds Goldman Sachs Group Inc GS Names Newmont Corporation NEM as Top Gold Sector Equity Pick for 2026 GameStops 555 Billion Unsolicited Acquisition Bid for eBay Why Global GWRS cost structure is getting attention GWRS Q4 2025 Earnings Global Misses Estimates Posts Loss Cerebras IPO Signals Intensifying AI Chip Race as Nvidia Faces New Rival Senate Confirms Kevin Warsh as Fed Chair A New Era for Monetary Policy Kevin Warsh Set to Be Sworn In as Federal Reserve Chair at White House This Week Horizon HSPTR Stock Consolidating at 030 Next Move Ahead 20260515 Fluent FLNT Drops 071 Key Support at 265 20260518 AvalonBay AVB Steady at 18615 Awaiting Next Catalyst 20260514 Local LOCL Stock Analysis Climbs 376 Eyes on 203 20260515 SoundHound AI SOUN Q1 2026 Earnings Miss EPS 006 vs 004 Expected Tyra Biosciences TYRA Slips Slightly as Stock Holds Between Key Support and Resistance Levels Prestige Consumer Healthcare PBH Gains Ground as Shares Advance Over 2 UnitedHealth Group UNH Holds Steady Amid Slight Decline Key Levels in Focus AAOI Q1 2026 Earnings EPS Misses Estimates as Revenue Details Remain Unclear Shares Rally Fed Minutes Reveal Potential Rate Hikes if Inflation Persists Warn of Iran Conflict Impact Iran Tariffs on Hormuz Internet Cables May Raise Europes Connectivity Costs Portugals Meo Sues State for 82 Million Over Huawei 5G Ban SP 500 Notches Modest Gains as Healthcare and Technology Outperform enVVeno Medical Q3 2025 Earnings Narrower Loss Beats Expectations as Clinical Programs Advance Symbotic SYM Q1 2026 Earnings EPS Misses Estimates Stock Rallies on Operational Optimism DDS Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Retail Environment BBAR Q4 2025 Earnings Earnings Beat Estimates Despite Stock Decline AEI Q1 2026 Earnings Narrowing Losses Amid Quiet Quarter Littelfuse Inc LFUS Gains 29 as Shares Approach Key Resistance MiniMed Group Inc MMED Rallies 256 as Shares Approach Key Resistance Gain Therapeutics GANX Bounces Back Testing Key Resistance at 187 Heritage HFWA Stock Start Here 053 20260420 Illumina Inc ILMN Launches DRAGEN v45 Bioinformatics Suite Expanding Addressable Market in Genomic Research and Clinical Oncology Market Wrap Tech leads sector gains consumer lags as indexes tick modestly lower Skillful EDTK Stock Is It Undervalued Touches High 20260420 Vanguard SP 500 ETF VOO Comparative Performance Analysis vs SCHD Amid 2026 Market Rotation Is BoA Pref 5 BMLL stock expensive relative to growth Regeneron Pharmaceuticals REGN Posts Positive Phase 3 Cemdisiran gMG Trial Data But Valuation Headwinds Persist